Bronchial responsiveness to inhaled methacholine in epidemiological studies: comparison of different indices. 1989

C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
Istituto di Tisiologia e Mal. App. Respir., Università di Pavia, Italy.

We evaluated the sensitivity and specificity of different indices drawn from the forced expiratory curve in order to detect the best one for evaluating bronchial reactivity in the general population, and particularly, for distinguishing between normal and asthmatic subjects. 654 subjects, between 15 and 64 years of age, who were representative for age and sex of the general population of a small Lombardy town (Italy), were studied. Of the total sample, 448 subjects were clinically normal and asymptomatic, 87 were symptomatic or with acute upper respiratory disease within 30 days before the challenge with methacholine, 43 with allergic rhinitis, 26 asthmatics and 50 chronic bronchitics. All the subjects who had a baseline FEV1 greater than 85% predicted underwent methacholine challenge. Provocative LnDoses of a 6, 10, 15% fall in FEV1 (LnPD6, LnPD10, LnPD15) and provocative LnDose causing FEV1 to fall more than 2 SD below the mean of 5 FEV1 measurements following buffer inhalation (LnTD) were evaluated. Furthermore we calculated the "Dose-Response slope" (SL) proposed by O'Connor. The cut-off value of each index to define a responder was calculated by discriminant analysis of the response to the challenge in normal and in the asthmatic group. Sensitivity, specificity and predictive value of LnPD6, LnTD and SL were 79, 74, 14%; 71, 74, 13% and 46, 97, 48% respectively. LnPD10 had the best sensitivity (83%) with a high specificity (83%), but, as compared to LnPD15, whose sensitivity was 79% and specificity 89%, a lower predictive value (21% vs 27%).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008688 Methacholine Compounds A group of compounds that are derivatives of beta-methylacetylcholine (methacholine). Compounds, Methacholine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D005540 Forced Expiratory Flow Rates The rate of airflow measured during a FORCED VITAL CAPACITY determination. Expiratory Forced Flow Rates,Flow Rates, Expiratory Forced,Flow Rates, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
June 1982, Journal of applied physiology: respiratory, environmental and exercise physiology,
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
March 1990, The New England journal of medicine,
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
July 1994, Thorax,
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
January 1988, Respiration; international review of thoracic diseases,
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
July 1993, Pediatric pulmonology,
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
September 1991, The Journal of allergy and clinical immunology,
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
January 1992, Internal medicine (Tokyo, Japan),
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
December 1998, Respirology (Carlton, Vic.),
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
December 1991, Arerugi = [Allergy],
C Bruschi, and I Cerveri, and M C Zoia, and L Maccarini, and M Grassi, and C Rampulla
February 1987, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!